AI adoption in pharma is accelerating, but field execution is lagging. The challenge is not access to technology. It is translating AI into compliant, real-world workflows that drive behavior change. This article explores how commercial leaders and L&D teams can move from mandate to measurable impact by aligning AI to field realities.

Microlearning is fast, scalable, and widely adopted, but it doesn’t build capability on its own. This article explores the gap between access and performance, and how to design learning that actually drives behavior change.